Terremoto Biosciences
Terremoto | A seismic shift is coming to drug discovery and development
- Business Model
- B2B
- Website
- terremotobio.com
- Total Funding
- $358.0M
- Last Round
- $108.0M Series CJan 2025
- Rounds
- 3
About
Clinical-stage biotech company using covalent chemistry to develop small molecule medicines for oncology and genetic disease.
Summary
Terremoto Biosciences is a Biotech company. It has raised $358.0M in total across 3 rounds, most recently a $108.0M Series C round in Jan 2025. Investors include OrbiMed, Third Rock Ventures and RA Capital Management.
Tech & App Stack
3 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jan 2025
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company